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ABSTRACT
Objective: Cirrhotic patients commonly undergo screening endoscopy for the existence
of esophageal varices. The use of this invasive procedure which is expensive, poorly
tolerable and generally not acceptable for the patients is increasing due to increasing
number of patients with chronic liver disease and their enriched survival. In this study, our
aim is to identify clinical, biochemical, and ultrasonography parameters which might noninvasively predict the presence of esophageal varices and risk of bleeding in patients with
liver cirrhosis. Material and Methods: Total 150 Patientsof chronic liver disease admitted
in ward-5, JPMC(Sep 2011-Feb 2012) with a complaint of hematemesis or melena were
included in the study. Platelet counts of 75,000 to 150,000/µL was defined as grade 1
thrombocytopenia, 50,000 to <75,000/µL as grade II, 25,000 to <50,000/µL as grade III
and below 25,000/µL as grade IV. The normal range for the INR is 0.8–1.2. Portal vein
size of 1.2 cm or above was taken as dilated. Spleen of >13 cm was considered as
enlarged in our study. Results: Out of 72 patients of variceal bleed 69 (46%) were males
and 81(54%) were females. Thrombocytopenia was present in 64 (88%) patients with
mean platelet count of 85.86/µL (±69.79). Deranged coagulation profile was present in
56 (77%) cases with mean INR of 1.63 (±0.5). Portal vein diameter (PVD) of >1.2 cm
was found in 46(63.8%) of patients with mean PVD of 1.22(±0.3023) and splenic size of
>13 cm was reported in 54 (75%) cases with mean splenic diameter of 14.5 cm (±2.39).
Conclusion: Thrombocytopenia, deranged coagulation profile, large splenic size, and dilated
portal vein strongly predict the risk of variceal bleeding.
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INTRODUCTION
In underdeveloped countries, liver cirrhosis is a major
cause of morbidity and mortality owing to unawareness
of the patients, inadequate facilities and financial
implications associated with the disease. In western
world chronic alcohol consumption account for majority
of the cases but in our part of the world infections by
hepatotropic viruses (Hepatitis B & C) are most likely
responsible. Liver cirrhosis follows an indolent course
and eventually patients succumb to the complications of
liver decompensation characterized by variceal bleeding
from portal hypertension, ascites, hepatorenal syndrome,

hepatic encephalopathy and spontaneous bacterial
peritonitis.1 Esophageal varices are generally the most
common clinical manifestation of portal hypertension and
ruptured esophageal varices are a dreaded complication of
portal hypertension, accounting for approximately 3200
deaths annually attributed to cirrhosis.2 Varices usually
form when hepatic vein pressure gradient (determinant
of portal pressure) exceeds 10 mmHg and bleeds when
it exceeds 12 mmHg. In cirrhosis, there is compression
of hepatic veins by regenerating nodules along with
collagen deposition in sinusoids and venules, factors
responsible for increased intrahepatic resistance. The
increase in blood flow is incompletely understood but is
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probably due to circulating vasodilators and alterations
in fluid and electrolyte balance. All these interactions
result in the development of increase portal pressure
and Porto‑systemic collateral formation. These collaterals
decompress the portal circulation by shunting the blood
to the heart via the systemic venous circulation and the
major sites of these collaterals are the esophagus, rectum,
umbilicus and retro peritoneum.3,4,5 Gastro esophageal
varices are present in approximately 50% of patients with
cirrhosis with a lifetime incidence of 90%. Their presence
also correlate with the severity of disease, being more
common in Child Pugh Class C patients as compared
to Child Pugh Class A patients (85% versus 40%)6,7,8
(Table 1). Variceal hemorrhage is a medical emergency.
Approximately one third of patients with esophageal
varices experience variceal bleeding with a mortality rate
of up to 20%. After an initial episode, there is 70% chance
of re-bleeding within a year with a mortality rate of up to
33% in the absence of any treatment9 Due to this reason
a screening endoscopy is indicated in all patients with
newly diagnosed cirrhosis to minimize the complications
and also to reduce mortality associated with acute variceal
bleed.2 It has also been suggested to repeat endoscopy
at every 2-3 years interval in patients without varices
and at 1-2 years interval in patients with small varices to
evaluate for progression10 Current treatment modalities
have substantially reduced the rate of first and recurrent
bleeding and has also decreased the mortality associated
with acute variceal bleed.11 However screening all patients
with endoscopy will significantly increase the cost and
has also variable patient compliance. A number of other
factors such as platelet count, coagulation profile, splenic
size and portal vein diameter also correlate with the risk
of variceal bleed and can be assessed by less invasive
and routine tests carried out on the patients of cirrhosis.
Due to cost effectiveness and to limit the number of
endoscopic procedures, these parameters become more
significant and carry paramount importance in making it
possible for endoscopy to be carried out only in selected
group of patients thus to avoid un-necessary intervention
and at the same time not to miss patients at risk of
bleeding. Therefore, the present study has been carried
out to identify clinical, biochemical and ultrasonographic
parameters which might non-invasively predict the
existence and the risk of variceal bleed.

1

2

3

<2
>3.5
None
None
<1.2

2‑3
2.8 ‑ 3.5
Mild
Mild
1.2 - 1.7

>3
<2.8
Moderate to severe
Moderate to severe
>1.7

Child A: 5‑6, Child B: 7‑9, Child C: 10-15
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A total of 150 patients with chronic liver disease,
admitted to the department of medicine, ward 5, Jinnah
Postgraduate Medical Centre from September 2011 to
February 2012 were included in this study. All patients
were categorized into two groups according to the
presence or absence of upper GI bleed in the form of
hematemesis or melena. Diagnosis of liver cirrhosis was
based on combination of clinical signs & symptoms,
laboratory findings (deranged coagulation profile, reversal
of albumin/globulin ratio) and Ultrasonographic findings
(size and echogenicity of the liver). Patients suffering from
acute liver failure, non‑cirrhotic portal hypertension, and
tropical splenomegaly were excluded from the study.
A structured proforma was used for data collection.
Detailed history was obtained and patients were examined
with special attention to anemia, jaundice, palmarerythema,
spider nevi, gynaecomastia, edema, splenomegaly
and ascites. Relevant hematological, biochemical and
radiological investigations were ordered including complete
blood count, urea, creatinine and electrolytes, liver function
tests, coagulation profile, serum proteins, serum albumin
and globulin ratio, HBsAg, Anti HCV Antibody, urine
D/R, ascetic fluid D/R, serum ammonia, chest X-Ray,
ultrasound abdomen and upper GI endoscopy (as part of
routine workup) (Table 2).
Upper gastrointestinal bleed was defined on the basis of
hematemesis or melena. Thrombocytopenia as platelet
count of <150,000/mm3, deranged coagulation profile
as INR of >1.2, splenomegaly as splenic size of >13 cm
anddilated portal vein diameter of>1.2 cm on ultrasound.
Platelet counts of 75,000 to 150,000/µL was defined as
grade I thrombocytopenia, 50,000 to 75,000/µL as grade II,
25,000 to 50,000/µL as grade III, and below 25,000/µL as
grade IV thrombocytopenia.
Statistical analysis was done using SPSS version 19 and
the results were obtained in the terms of frequencies and
percentages for descriptive analysis. Chi-Square and student
t tests were used to analyze the numerical data and p value
of <0.05 was set to be statistically significant.

RESULTS

Table 1: Child pugh classification
Bilirubin (mg/dl)
Serum albumin (g/dl)
Grade of encephalopathy
Grade of ascites
INR

MATERIAL AND METHOD

Age & Gender

There were eighty one (n=81, 54%) females and sixty
nine (n=69, 46%) males. The range of patient’s age was
14-83 yrs. 58% (n=87) of the patients in our study belong to
the age group of 40 – 60 years with mean age of 50.9 years
and Standard deviation of ±13.171 (Figures 1 & 2).
Asian Journal of Medical Sciences | Jan-Mar 2015 | Vol 6 | Issue 1
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Table 2: Laboratory parameters of all patients with chronic liver disease
Without bleed
Hemoglobin (mg/dl)
Mean cell volume (fl)
TLC (x109/L)
Platelets/mm3
Random blood sugar (mg/dl)
Urea (mg/dl)
Creatinine (mg/dl)
Serum sodium (meq/l)
Serum potassium (meq/l)
Serum chloride (meq/l)
Total bilirubin (mg/dl)
Direct bilirubin (mg/dl)
Indirect bilirubin (mg/dl)
ALT (u/l)
AST (u/l)
ALP (u/l)
GGT (u/l)
Total proteins (mg/dl)
Serum albumin (mg/dl)
Globulin (mg/dl)
A/G ratio
INR
Serum ammonia (μg/dl)
Liver span (cm)
Portal vein diameter (cm)
Spleen size (cm)
Splenic vein diameter (cm)

With bleed

p-value

Mean

Std. Deviation

Mean

Std. Deviation

8.429
88.421
8.790
113.96
137.58
57.09
1.4016
132.472
4.2748
102.746
4.2211
1.9992
2.1063
44.81
85.15
372.20
58.13
8.141
3.125
4.037
0.810
1.3731
164.00
11.562
1.092
13.082
1.167

2.2389
14.1289
6.1854
67.188
84.530
47.601
1.04940
7.1617
3.40198
8.4363
5.38458
3.25431
2.44664
53.126
64.431
285.201
74.675
7.1363
0.5835
0.9202
0.1880
0.45532
74.740
2.1332
0.2583
2.3503
0.2066

8.184
91.584
8.453
86.10
137.64
52.11
1.1420
133.277
3.9015
103.127
3.3395
1.6781
1.6953
51.90
99.00
296.13
47.33
8.202
3.623
3.677
0.845
1.6385
253.33
12.029
1.224
14.565
0.700

2.0675
10.0995
5.7380
69.645
68.215
35.582
0.61934
9.3108
0.75980
6.2709
3.87788
2.40724
1.72525
39.677
109.509
226.103
35.865
9.6373
4.1489
0.8849
0.2007
0.50358
98.845
3.3295
0.3023
2.3994
0.2828

0.492
0.142
0.739
0.012*
0.997
0.492
0.084
0.578
0.400
0.792
0.300
0.540
0.300
0.428
0.439
0.118
0.358
0.970
0.376
0.050
0.390
0.001*
0.016*
0.584
0.007*
0.000*
0.041*

* Significant P-value
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Figure 1: Age prevalence

Frequency of viral hepatitis

The most common cause of chronic liver disease was found
to be HCV in our patients. Frequency of viral hepatitis as
a cause of chronic liver disease is mentioned in Figure 3.
Frequency of upper GI bleed

72 patients in our study presented with GI Bleed that makes
48% of total cases while 78 patients (52%) patients had no
history of upper GI bleed. Out of 72 patients, 22 (15%)
patients presented with hematemesis, 12 (8%) had melena
Asian Journal of Medical Sciences | Jan-Mar 2015 | Vol 6 | Issue 1
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Figure 2: Gender prevalence

and 38 (25%) patients presented with both hematemesis
and melena (Figure 4).

NON-INVASIVE PARAMETERS FOR ESOPHAGEAL
VARICES
Thrombocytopenia

Thrombocytopenia was present in 64 (88%) patients,
with mean platelet count of 85.86/µL (±69.79) in
63
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patients with upper GI bleed. While 63 patients with
no history of upper GI bleed had thrombocytopenia
with mean platelet count of 113.96 (p-value 0.014).
Statistically significant relationship was found between
the severity of thrombocytopenia and risk of bleed
in CLD patients (Figure 5) (Pearson’s Chi Square:
p value = 0.009).

1RQH
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Portal vein diameter of >1.2 cm was found in 46 (63.8%)
patients who presented with GI Bleed with mean PVD
of 1.22 cm (±0.3023), (p value = 0.005) while 35 (44.8%)
patients without bleed had dilated portal vein on ultrasound
with mean PVD of 1.092 cm (±0.02). Level of significance
was determined by application of Pearson chi square
(p-value 0.022) (Figure 7).







Splenic size

A splenic size of >13 cm was found in 54 (75%) cases
having mean splenic diameter of 14.5 cm(±2.39)(p value
<0.001). On the other hand, 35 (44%) patients without GI
Bleed had splenomegaly with mean splenic diameter of
13.08 cm (±2.35). Level of significance was determined
by application of Pearson chi square (p-value 0.000)
(Figure 8).

Figure 3: Frequency of viral hepatitis
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Deranged coagulation profile was present in 56 (77%)
cases with GI Bleed, with mean INR of 1.63 (±0.5) in
contrast to only 39 patients (50%) without upper GI Bleed
had deranged coagulation profile with a mean INR of
1.37 (±0.45)(p value = 0.001). Level of significance was
determined by application of Pearson chi square (p-value
0.001) (Figure 6).
Portal vein diameter
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Coagulation profile
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DISCUSSION






Acute Upper GI hemorrhage is a medical emergency with
high morbidity and mortality, numerous hospital admissions
and a high burden on health care providers.12,13 Esophageal
varices are the major cause of upper GI hemorrhage in our
setting as compared to peptic ulcer in western population.
Despite significant improvements in early diagnosis and
advancements made in the treatment modalities, the
mortality rate of first variceal hemorrhage is still 20%.
Numerous studies have demonstrated the significance
of pharmacologic therapy for primary prevention of







Figure 4: Frequency of upper GI bleed
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Figure 5: Grades of thrombocytopenia vs GI bleed (statistically significant difference was found between the groups by applying Pearson Chi
Square (p-value 0.005))
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Figure 6: Coagulation profile vs GI bleed
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Figure 8: Splenomegaly vs GI bleed

variceal bleeding, emphasizing the importance of screening
endoscopy in all newly diagnosed cirrhotic patients for
the presence of varices.9,14 Therefore, there is a particular
need for the identification of noninvasive parameters that
strongly predict the presence of esophageal varices as that
might decreases the medical, public and economic burden
of the disease.
Our Study demonstrated that thrombocytopenia, deranged
coagulation profile, presence of portal hypertension with
splenomegaly and portal vein diameter are strong predictors
of developing variceal bleed presenting clinically as upper
GI hemorrhage.
Earlier, the pathophysiology of thrombocytopenia in liver
disease was linked to the presence of hyperspleenism,
but now it has been discovered that thrombopoetin
production is dependent on functioning liver cell mass
Asian Journal of Medical Sciences | Jan-Mar 2015 | Vol 6 | Issue 1

and is responsible for reduced thrombopoiesis and
consequently peripheral thrombocytopenia in patients of
advanced liver disease.15,16 Prolonged PT is also related
to the severity of liver diseases and is also a simple,
inexpensive and accurate marker of liver impairment and
a predictor of upper gastrointestinal bleeding in chronic
liver disease.17
Splenomegaly and portal vein diameter are also reliable
predictors of variceal hemorrhage, in a study carried
out by Mandal et al18 it has been shown that grading of
esophageal varices also correlate with splenic size and
portal vein diameter. In their study average portal vein
diameter and splenic size in high grade varices were 14.43
± 0.86 mm and 15.36 ± 2.14 cm. Sharma and Agarwal in
their study had noted that clinically palpable spleen was
associated with high grade varices however they did not
measure the splenic size radiologically.19 The measurement
of the splenic diameter using ultrasonography is easily
obtainable, reproducible, non-invasive and is routinely
performed on patients with cirrhosis. In another study
carried it was demonstrated that the platelet count/
spleen diameter ratio is also useful in the discrimination
of large versus small varices and in their study a platelet
spleen diameter ratio of less than 909 was statistically
significant in predicting large varices.20 Farooqi et al21 also
found out that platelet count of < 65 x 103/µL, serum
albumin <2.2 g/dl and portal vein diameter of >13 mm
are independent and significant predictors of esophageal
varices on endoscopy.
Though, upper GI endoscopy remains the gold standard
for the diagnosis of esophageal varices in cirrhotic patients,
from the present study and a number of other studies it
has been found that certain non-endoscopic parameters
such as thrombocytopenia (<75,000/mm3), coagulation
profile (PT >1.3), spleen size (>13 cm), and portal vein
diameter (>1.2 cm) are significant and reliable predictors
of esophageal varices on endoscopy, therefore screening
endoscopy could be safely limited to the group of cirrhotic
patients with no history of upper GI bleed but in the
presence of above deranged parameters.
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